<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04939571</url>
  </required_header>
  <id_info>
    <org_study_id>EU-ROP</org_study_id>
    <nct_id>NCT04939571</nct_id>
  </id_info>
  <brief_title>European Disease Registry on Retinopathy of Prematurity (ROP)</brief_title>
  <acronym>EU-ROP</acronym>
  <official_title>European Disease Registry on Retinopathy of Prematurity (ROP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medicine Greifswald</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The EU-ROP registry is a European wide multicenter non-interventional observational registry&#xD;
      study intended to run open-ended in as many countries as possible including infants treated&#xD;
      for retinopathy of prematurity irrespective of the used treatment modality. The registry is&#xD;
      strictly observational; only clinical routine data is collected, no study-specific&#xD;
      examinations or interventions are to be performed.&#xD;
&#xD;
      The aim of the EU-ROP registry is to collect information on as many patients as possible&#xD;
      treated for ROP in Europe. Both the number of study centers as well as the number of patients&#xD;
      to be included into the registry are not limited.&#xD;
&#xD;
      The primary objective is to describe the typical clinical features of infants with severe&#xD;
      ROP, variations in phenotype, and the clinical progression of the disease over time (natural&#xD;
      history) in different European countries as well as to study treatment patterns, follow-up&#xD;
      patterns, as well as long-term outcomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 6, 2021</start_date>
  <completion_date type="Anticipated">August 2039</completion_date>
  <primary_completion_date type="Anticipated">August 2038</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>18 Years</target_duration>
  <primary_outcome>
    <measure>Baseline data of preterm born infants who develop treatment-requiring retinopathy of prematurity</measure>
    <time_frame>Birth to treatment of ROP, an average of 12 weeks</time_frame>
    <description>Birth weight, gestational age, weight at treatment, comorbidities (e.g. sepsis, necrotizing enterocolitis)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment parameters at initial treatment</measure>
    <time_frame>An average of 12 weeks postnatal age</time_frame>
    <description>Type of treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment parameters at re-treatment</measure>
    <time_frame>Through study completion, an average of 20 to 30 weeks postnatal age</time_frame>
    <description>Type of treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ROP stage</measure>
    <time_frame>Through follow-up after treatment, an average of 1 year postnatal age</time_frame>
    <description>Stage of ROP at treatment and during follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Long-term ophthalmic development</measure>
    <time_frame>Up to 18 years</time_frame>
    <description>Ophthalmic development (e.g. orthoptic status, visual acuity)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term neurologic development</measure>
    <time_frame>Up to 18 years</time_frame>
    <description>Neurological developmental (e.g. assessed by psychometric assessments)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Retinopathy of Prematurity</condition>
  <arm_group>
    <arm_group_label>Preterm born infants treated for ROP</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Registry of preterm born infants with treatment-requiring ROP</intervention_name>
    <description>All prematurely born infants who develop treatment requiring ROP and are treated (independent of the kind of treatment modality) at a center that participates in the registry are eligible for database entry.</description>
    <arm_group_label>Preterm born infants treated for ROP</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All infants Europe wide with ROP requiring treatment can be entered into the registry. The&#xD;
        aim of the EU-ROP registry is to collect information on as many patients as possible&#xD;
        treated for ROP in Europe. Both the number of study centers as well as the number of&#xD;
        patients to be included into the registry are not limited.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ROP requiring treatment according to the respective national ROP screening and&#xD;
             treatment guidelines&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Denial or absence of consent for documentation and electronic storage of personal data&#xD;
             by parents or legal guardians&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Stahl, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ophthalmology, University Medicine Greifswald</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andreas Stahl, Professor</last_name>
    <phone>+49 3834 86</phone>
    <phone_ext>5900</phone_ext>
    <email>andreas.stahl@med.uni-greifswald.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Johanna M Pfeil, Dr</last_name>
    <phone>+49 3834 86</phone>
    <phone_ext>5900</phone_ext>
    <email>johanna.pfeil@med.uni-greifswald.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Aachen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Walter</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital Helios</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helge Breuss</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital Vivantes</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabine Aisenbrey</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Chemnitz</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Imke Bachmann</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Cologne</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim U Krohne</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Düsseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rainer Guthoff</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fanni Molnar</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Greifswald</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Stahl</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Göttingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Bemme</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Spitzer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Lübeck</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vinodh Kakkassery</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Münster</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Glitz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Regensburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Barth</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Tübingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Süsskind</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 1, 2021</study_first_submitted>
  <study_first_submitted_qc>June 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2021</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ROP</keyword>
  <keyword>anti-VEGF</keyword>
  <keyword>laser coagulation</keyword>
  <keyword>epidemiology</keyword>
  <keyword>non-interventional study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Retinopathy of Prematurity</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

